当前位置: 首页 > 期刊 > 《中国医学创新》 > 2017年第6期
编号:13005028
子宫内膜异位症发病机制及其治疗分类研究(4)
http://www.100md.com 2017年2月25日 《中国医学创新》 2017年第6期
     [19] Richard,Burney,Linda C,Giudice.Pathogenesis and pathophysiology of endometriosis[J].Fertility and Sterility,2012,98(3):511-519.

    [20] Bartley J,Jülicher A,Hotz B,et alEpithelial to mesenchymal transition (EMT) seems to be regulated differently in endometriosis and the endometrium[J].Archives of Gynecology and Obstetrics,2014,289(4):871-881.

    [21] Bass L C,Dillard T A,Forseen C J,et al.An Unusual Cause of Massive Pleural Effusion[J].The American Journal of the Medical Sciences,2012,344(6):505-507.

    [22] Cho S,Jung J A,Lee Y,et al.Postoperative levonorgestrel‐releasing intrauterine system versus oral contraceptives after gonadotropin‐releasing hormone agonist treatment for preventing endometrioma recurrence[J].Acta Obstetricia Et Gynecologica Scandinavica,2014,93(1):38-44.

    [23] Kong S,Zhang Y H,Liu C F,et al.The complementary and alternative medicine for endometriosis:a review of utilization and mechanism[J].Evidence-Based Complementary and Alternative Medicine,2014,2014(1):146 383.

    [24] Li M Q,Shao J,Meng Y H,et al.NME1 suppression promotes growth,adhesion and implantation of endometrial stromal cells via Akt and MAPK/Erk1/2 signal pathways in the endometriotic milieu[J].Human Reproduction,2013,28(10):2822-2831.

    (收稿日期:2016-12-21) (本文編辑:张爽), http://www.100md.com(刘瑞景 蔡海燕)
上一页1 2 3 4